Is DexCom Stock a Buy Now?
If you were to strictly look at earnings multiples, you could easily miss a top growth stock like DexCom (NASDAQ: DXCM). Initially, value investors might scoff at the whopping 200+ times earnings that it trades at right now. But that wouldn't tell you the whole story.
The reality is that DexCom makes some highly coveted continuous glucose monitoring (CGM) devices that can be game-changers for people with diabetes, allowing them to easily stay on top of their glucose levels. And that can lead to some significant growth down the road. Should investors worry about the stock's seemingly high valuation or look past it?
Image source: Getty Images.
Source Fool.com
